Treatment Information

Back

Liver Cancer treatment details. Biologic therapy.

Santa Clara Valley Medical Center, San Jose, California, United States.

Survival: monthsCountry:United States
Toxiciy Grade:4City/State/Province:San Jose, California
Treatments:Biologic therapyHospital:Santa Clara Valley Medical Center
Drugs:Journal:Link
Date:Jan 2005

Description:

Patients: This Phase II study involved 27 patients with unresectable hepatocellular carcinoma, 21 men and 6 women. The median age was 62 years.

Treatment: Treatment consisted of one biological therapy - thalidomide. Thalidomide decreases the formation of new blood vessels.

Toxicity: Grade 3-4 toxicities included anemia, fatigue, somnolence, elevated enzymes, and elevated bilirubin.

Results: The median survival was 4 months.

Support: This study was supported in part by Celgene Inc. Celgene manufactures thalidomide.

Correspondence: Albert Lin, MD





Back